Christopher Paul German sold $428K of Rhythm Pharmaceuticals (RYTM)

Executed May 15, disclosed May 19, 4 days later.

Value, as filed

$428K

4,643 sh × $92.21

Executed

May 15

the trade date, as filed

Disclosed

May 19

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

CG Christopher Paul German Corporate Controller & CAO profile →

Christopher Paul German (Corporate Controller & CAO) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Rhythm Pharmaceuticals, Inc. (RYTM). The largest single filing was $503K of RYTM (5,614 sh × $89.56, as filed), executed Mar 4.

The name

RYTM Rhythm Pharmaceuticals, Inc. RYTM · Healthcare · 47 filings in 24 months ticker →

Healthcare · Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases in the United State…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Christopher Paul German in RYTM

RYTMSALE Rhythm Pharmaceuticals, Inc. $503K
5,614 sh × $89.56
Exec Mar 4
Filed Mar 6 · 5:30 PM ET RYTMSALE Rhythm Pharmaceuticals, Inc. $142K
1,500 sh × $95.00
Exec Aug 12 2025
Filed Aug 14 2025 · 5:30 PM ET RYTMSALE Rhythm Pharmaceuticals, Inc. $308K
3,817 sh across 2 lots
Exec Jul 9 2025
Filed Jul 11 2025 · 5:30 PM ET RYTMSALE Rhythm Pharmaceuticals, Inc. $139K
2,069 sh × $67.19
Exec Jun 10 2025
Filed Jun 12 2025 · 5:30 PM ET